LIONNS-D2 Project – Production of T3S API, IMP and FDF
This is a contract result notice, not an open opportunity. Details from the official award data.
Cardiff University’s School of Medicine is procuring the manufacture of a novel investigational medicinal product (IMP), Triiodothyronine sulphate (T3S), for use in a Phase 2b clinical trial.
The service includes the production of the active pharmaceutical ingredient (API), the IMP, and the finished drug formulation (FDF) in blister packs.
This bespoke drug is intended for hypothyroid patients with a specific genetic variation affecting thyroid hormone metabolism.
The supplier will manufacture the product to GMP standards, using a validated Route of Synthesis supported by existing preclinical and toxicology data.
Make the case to bid
Reveal who to approach at Cardiff University, and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-05d2df
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 067987-2025
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Cardiff University’s tender network
Assembling the network…